CORRESP 1 filename1.htm

 

September 28, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission

100 F. Street, NE

Washington, DC 20549

 

Attn: Scott Stringer
  Joel Parker
  Brian Fetterolf
  Erin Jaskot

 

  Re: Syra Health Corp.
    Registration Statement on Form S-1, as amended
    File No. 333-271622

 

Ladies and Gentlemen:

 

As representative of the several underwriters of the proposed offering of Syra Health Corp. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness at 4:30 p.m., Eastern Time, on Thursday, September 28, 2023, or as soon thereafter as possible. 

   

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

  

  Sincerely,
     
  Kingswood, a division of Kingswood Capital Partners, LLC
     
  By: /s/ Tyler Bashaw
  Name: Tyler Bashaw

 

Title: Director